Special Article: Chronic granulomatous disease in the United Kingdom and Ireland: A comprehensive national patient-based registry

Clinical and Experimental Immunology

Volumn 152, Issue 2, 2008, Pages 211-218

  Jones, L B K R ^a   McGrogan, P ^a   Flood, T J ^b   Gennery, A R ^a,b   Morton, L ^c   Thrasher, A ^c,d   Goldblatt, D ^c,d   Parker, L ^a   Cant, A J ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Aspergillus infection; Chronic granulomatous disease; Colitis; Pneumonia; Staphylococcal infection

Indexed keywords

GAMMA INTERFERON;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHRONIC GRANULOMATOUS DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE REGISTRY; EMPYEMA; FEMALE; GROWTH DISORDER; HUMAN; IRELAND; LIVER ABSCESS; LUNG ABSCESS; MALE; MORBIDITY; OSTEOMYELITIS; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; SEPTICEMIA; STEM CELL TRANSPLANTATION; UNITED KINGDOM; X CHROMOSOME LINKED DISORDER;

EID: 42049108433     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03644.x     Document Type: Article

References (31)

1. Berendes H, Bridges RA, Good RA. A fatal granulomatosus of childhood. Minn Med 1957 40 : 309 12.
2. Landing BH, Shirkey HA. A syndrome of recurrent infection and infiltration of viscera by pigmented lipid histiocytes. Pediatrics 1957 20 : 431 8.
3. Segal AW, Peters TJ. Characterisation of the enzyme defect in chronic granulomatous disease. Lancet 1976 1 : 1363 5.
4. Curnutte JT, Whitten D, Babior BM. Defective superoxide production by granulocytes from patients with chronic granulomatous disease. N Engl J Med 1974 290 : 593 7.
5. Dinauer MC, Orkin SH, Brown R, Jesaitis AJ, Parkos CA. The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature 1987 327 : 717 20.
6. Smith RM, Curnutte JT. Molecular basis of chronic granulomatous disease. Blood 1991 77 : 673 87.
7. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical and clinical features of chronic granulomatous disease. Medicine 2000 79 : 170 200.
8. Ahluwalia J, Tinker A, Clapp LH et al. The large-conductance Ca2+-activated K+ channel is essential for innate immunity. Nature 2004 427 : 853 8.
9. Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 1989 114 : 555 60.
10. Goldblatt D, Thrasher AJ. Chronic granulomatous disease. Clin Exp Immunol 2000 122 : 1 9.
11. Hitzig WH, Seger R. Chronic granulomatous disease, a heterogeneous syndrome. Hum Genet 1983 64 : 207 15.
12. Ament ME, Ochs HD. Gastrointestinal manifestations of chronic granulomatous disease. N Engl J Med 1973 288 : 382 7.
13. Schappi MG, Smith VV, Goldblatt D, Lindley KJ, Milla PJ. Colitis in chronic granulomatous disease. Arch Dis Child 2001 84 : 147 51.
14. Marciano BE, Rosenzweig SD, Kleiner DE et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 2004 114 : 462 8.
15. Baehner RL, Boxer LA, Davis J. The biochemical basis of nitroblue tetrazlium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes. Blood 1976 48 : 309 13.
16. Vowells S, Sekhsaria S, Malech HL, Shalit M, Fleisher TA. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods 1995 178 : 89 97.
17. Finn A, Hadzic N, Morgan G, Strobel S, Levinsky RJ. Prognosis of chronic granulomatous disease. Arch Dis Child 1990 65 : 942 5.
18. Liese JG, Jendrossek V, Jansson A et al. Chronic granulomatous disease in adults. Lancet 1996 347 : 220 3.
19. Cale CM, Jones AM, Goldblatt D. Follow up of patients with chronic granulomatous disease diagnosed since. Clin Exp Immunol 2000 since 1990 120 : 351 5.
20. Ahlin A, De Boer M, Roos D et al. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatrica 1995 84 : 1386 94.
21. Winkelstein JA, Marino MC, Johnston RB et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine 2000 79 : 155 69.
22. Hasui M. Chronic granulomatous disease in Japan: incidence and natural history. Pediatr Int 1999 41 : 589 93.
23. Aghamohammadi A, Moein M, Farhoudi A et al. Primary immunodeficiency in Iran: first report of the national registry of PID in children and adults. J Clin Immunol 2002 22 : 375 80.
24. Martire B, Rondelli R, Soresina A et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol 2008 126 : 155 64.
25. Weening RS, Adriaansz LH, Weemaes CM, Lutter R, Roos D. Clinical differences in chronic granulomatous disease in patients with cytochrome b-negative or cytochrome b positive neutrophils. J Pediatr 1985 107 : 102 4.
26. Fischer A, Segal AW, Seger R, Weening RS. The management of chronic granulomatous disease. Eur J Pediatr 1993 152 : 896 9.
27. Ezekowitz RAB, Gallin JI, Mallech HL. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991 324 : 509 16.
28. Soler-Palacín P, Margareto C, Llobet P et al. Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immunopathol (Madr) 2007 35 : 83.
29. Liese J, Kloos S, Jendrossek V et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 2000 137 : 687 93.
30. Horwitz ME, Barrett AJ, Brown MR et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med 2001 344 : 881 8.
31. Seger RA, Gungor T, Belohradsky BH et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood 2002 100 : 4344 50.